Results 151 to 160 of about 33,936 (220)

Combinational studies of BOLD-100/KP1339 with established chemotherapeutics in gastrointestinal multicellular tumor spheroids. [PDF]

Cancer Chemother Pharmacol
Wenisch D, Ždravac S, Jakupec MA, Jirsa F, Keppler BK.   +4 more
europepmc   +1 more source

LISS enables immune evasion of colorectal cancers irrespective of MSI status. [PDF]

Signal Transduct Target Ther
Lin Q, Wang X, Zhao W, Song S, Zhang Y, Ma J, Li T, Wei Y, Lu M, Hou G, Wang M, Liu H, Zheng S, Burenina O, Xiang Z, Li L, Zhu J, Hu Y.   +17 more
europepmc   +1 more source

RNA Metabolism Genes as Prognostic Biomarkers and Therapeutic Targets in Colorectal Cancer Based on the Analysis of Single-Cell and Bulk-RNA Sequencing Data. [PDF]

J Cell Mol Med
Kong F, Zhang X, Su S, Chen F, Ye Q, Yang R, Du H.   +6 more
europepmc   +1 more source

The anti-migratory effect of curcumin in colorectal cancer involves IKKβ/NF-κB/Snail-mediated EMT inhibition. [PDF]

Transl Cancer Res
Liu B, Xiao L, Shi J, Zhang J, Chen M.
europepmc   +1 more source

Multifaceted MRVI1 Serves as a Tumor Suppressor in HCT116 Colorectal Cancer Cells

Biological and Pharmaceutical Bulletin
Kosuke Higashi, Yangsu Cho, Kazumasa Aoyama   +2 more
openaire   +1 more source

Integrated multi-omics analysis suggests the involvement of PI3K-Akt/p21 signaling in the anti-colorectal cancer effects of <i>Diaphragma Juglandis Fructus</i> extract. [PDF]

Front Pharmacol
Yang Y, Xu Y, Cheng H.
europepmc   +1 more source

The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells. [PDF]

J Cell Biochem, 2018
Zuo Q, Wu R, Xiao X, Yang C, Yang Y, Wang C, Lin L, Kong AN.   +7 more
europepmc   +1 more source

NOP56 Drives Colorectal Cancer Progression by Modulating p53 Acetylation through SIRT1/p300. [PDF]

Int J Biol Sci
Park JE, Ahn CH, Sim DY, Park SY, Cha HJ, Shim BS, Kim B, Kim SH.   +7 more
europepmc   +1 more source

HIF1-driven TDP-43 stabilizes TRIP6 mRNA to drive angiogenesis and colorectal cancer progression under hypoxia. [PDF]

Transl Oncol
Cheng K, Liu Y, Feng W, Xu D, Hao B.
europepmc   +1 more source

Correction: Polo-like kinase 3 inhibits glucose metabolism in colorectal cancer by targeting HSP90/STAT3/HK2 signaling. [PDF]

J Exp Clin Cancer Res
Ou B, Sun H, Zhao J, Xu Z, Liu Y, Feng H, Peng Z.   +6 more
europepmc   +1 more source